Through our British registered sister charity
What We Do
HIV / AIDS, TB & Malaria
Community based health care
Children & Women's Rights
Scope of Research
Research Policy & planning
How You Can Help
Global Learning Resources
How to Donate
Back to News
ICROSS working on innovative ways to treat Trachoma since 1986
ICROSS has been working on innovative ways to treat Trachoma since 1986 with Professor David Morley of the Institute of Child Health, a pioneer of Tropical Health.
Trachoma is the leading infectious cause of blindness worldwide. It is caused by an obligate intracellular bacterium called
. The infection is transmitted through contact with eye and nose discharge of infected people, particularly young children who harbour the principal reservoir of infection. It is also spread by flies which have been in contact with the eyes and noses of infected people. ICROSS has been developing new techniques to control the spread of Trachoma using different types of low cost technologies in remote Rural East Africa. For 30 years ICROSS has been working with international research bodies including the World Health Organisation on creating effective sustainable prevention of the disease.
Trachoma is a disease of the eye caused by infection with the bacterium
It is known to be a public health problem in 42 countries, and is responsible for the blindness or visual impairment of about 1.9 million people. Just over 200 million people live in trachoma endemic areas and are at risk of trachoma blindness.
Blindness from trachoma is irreversible.
Infection spreads through personal contact (via hands, clothes or bedding) and by flies that have been in contact with discharge from the eyes or nose of an infected person. With repeated episodes of infection over many years, the eyelashes may be drawn in so that they rub on the surface of the eye, with pain and discomfort and permanent damage to the cornea.
ICROSS continues to develop new innovative research to reduce infection rates and prevent blindness.
Back to News
Print this article
© ICROSS International 2017.